The Next Step for MRD in Myeloma? Treating MRD Relapse after First Line Treatment in the REMNANT Study

Share "The Next Step for MRD in Myeloma? Treating MRD Relapse after First Line Treatment in the REMNANT Study"

N/A

Protected

Studieår: 2022

Info

Protected

Academic year: 2022

Share "The Next Step for MRD in Myeloma? Treating MRD Relapse after First Line Treatment in the REMNANT Study"

Copied!

Fulltekst

Referanser

RELATERTE DOKUMENTER

$OCEAN: a randomized Phase III study of melflufen + dexamethasone to treat relapsed refractory multiple myeloma$